Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Scambia

Showing results (511-520 of 551) with videos related to

Pageof 56
Sort By:
ESMO Open|September 4, 2025
Gene actionability according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) in No Specific Molecular Profile (NSMP) endometrial cancerL Mastrantoni, F Camarda, C Parrillo, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 25, 2020
Imaging in gynecological disease (20): clinical and ultrasound characteristics of adnexal torsionF Moro, G Bolomini, M Sibal, et al.
Facts, Views & Vision in Obgyn|October 2, 2024
Utility of routine preoperative laboratory testing for patients undergoing minor gynaecologic surgical procedures: interim analysis of their impact on intraoperative and postoperative complicationsU Catena, A Biasioli, C Paglietti, et al.
Gynecologic Oncology|July 19, 2017
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: A multicentre MITO retrospective studyF Falcone, G Scambia, P Benedetti Panici, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction modelsC Capalbo, E Ricevuto, A Vestri, et al.
International Journal of Cancer|August 22, 1995
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasA Bellacosa, D de Feo, A K Godwin, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 22, 2012
Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal massesA Di Legge, A C Testa, L Ameye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trialD Lorusso, G Scambia, S Pignata, et al.
ESMO Open|January 23, 2025
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus StudyL Incorvaia, C Marchetti, C Brando, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 17, 2017
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgeryA C Testa, G Ferrandina, F Moro, et al.
Pageof 56

Showing results (511-520 of 551) with videos related to

Sort By:
Pageof 56
ESMO Open|September 4, 2025
Gene actionability according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) in No Specific Molecular Profile (NSMP) endometrial cancerL Mastrantoni, F Camarda, C Parrillo, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 25, 2020
Imaging in gynecological disease (20): clinical and ultrasound characteristics of adnexal torsionF Moro, G Bolomini, M Sibal, et al.
Facts, Views & Vision in Obgyn|October 2, 2024
Utility of routine preoperative laboratory testing for patients undergoing minor gynaecologic surgical procedures: interim analysis of their impact on intraoperative and postoperative complicationsU Catena, A Biasioli, C Paglietti, et al.
Gynecologic Oncology|July 19, 2017
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: A multicentre MITO retrospective studyF Falcone, G Scambia, P Benedetti Panici, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction modelsC Capalbo, E Ricevuto, A Vestri, et al.
International Journal of Cancer|August 22, 1995
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasA Bellacosa, D de Feo, A K Godwin, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 22, 2012
Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal massesA Di Legge, A C Testa, L Ameye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trialD Lorusso, G Scambia, S Pignata, et al.
ESMO Open|January 23, 2025
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus StudyL Incorvaia, C Marchetti, C Brando, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 17, 2017
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgeryA C Testa, G Ferrandina, F Moro, et al.
Pageof 56